General Information of the Protein
Protein ID
PT06444
Protein Name
Glutamate receptor ionotropic, NMDA 2B
Secondarily
Protein Name
Glutamate [NMDA] receptor subunit epsilon-2
N-methyl D-aspartate receptor subtype 2B
Gene Name
GRIN2B
Sequence
MKPSAECCSPKFWLVLAVLAVSGSKARSQKSAPSIGIAVILVGTSDEVAIKDAHEKDDFHHLSVVPRVELVAMNETDPKSIITRICDLMSDRKIQGVVLADDTDQEAIAQILDFISAQTLTPILGIHGGSSMIMADKDESSMFFQFGPSIEQQASVMLNIMEEYDWYIFSIVTTYFPGYQDFVNKIRSTIENSFVGWELEEVLLLDMSLDDGDSKIQNQLKKLQSPIILLYCTKEEATYIFEVANSVGLTGYGYTWIVPSLVAGDTDTVPSEFPTGLISVSYDEWDYGLPARVRDGIAIITTAASDMLSEHSFIPEPKSSCYNTHEKRIYQSNMLNRYLINVTFEGRNLSFSEDGYQMHPKLVIILLNKERKWERVGKWKDKSLQMKYYVWPRMCPETEEQEDDHLSIVTLEEAPFVIVESVDPLSGTCMRNTVPCQKRIISENKTDEEPGYIKKCCKGFCIDILKKISKSVKFTYDLYLVTNGKHGKKINGTWNGMIGEVVMKRAYMAVGSLTINEERSEVVDFSVPFIETGISVMVSRSNGTVSPSAFLEPFSADVWVMMFVMLLIVSAVAVFVFEYFSPVGYNRCLADGREPGGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEYVDQVSGLSDKKFQRPNDFSPPFRFGTVPNGSTERNIRNNYAEMHAYMGKFNQRGVDDALLSLKTGKLDAFIYDAAVLNYMAGRDEGCKLVTIGSGKVFASTGYGIAIQKDSGWKRQVDLAILQLFGDGEMEELEALWLTGICHNEKNEVMSSQLDIDNMAGVFYMLGAAMALSLITFICEHLFYWQFRHCFMGVCSGKPGMVFSISRGIYSCIHGVAIEERQSVMNSPTATMNNTHSNILRLLRTAKNMANLSGVNGSPQSALDFIRRESSVYDISEHRRSFTHSDCKSYNNPPCEENLFSDYISEVERTFGNLQLKDSNVYQDHYHHHHRPHSIGSTSSIDGLYDCDNPPFTTQPRSISKKPLDIGLPSSKHSQLSDLYGKFSFKSDRYSGHDDLIRSDVSDISTHTVTYGNIEGNAAKRRKQQYKDSLKKRPASAKSRREFDEIELAYRRRPPRSPDHKRYFRDKEGLRDFYLDQFRTKENSPHWEHVDLTDIYKERSDDFKRDSVSGGGPCTNRSHLKHGTGDKHGVVGGVPAPWEKNLTNVDWEDRSGGNFCRSCPSKLHNYSSTVAGQNSGRQACIRCEACKKAGNLYDISEDNSLQELDQPAAPVAVSSNASTTKYPQSPTNSKAQKKNRNKLRRQHSYDTFVDLQKEEAALAPRSVSLKDKGRFMDGSPYAHMFEMPAGESSFANKSSVTTAGHHHNNPGSGYMLSKSLYPDRVTQNPFIPTFGDDQCLLHGSKSYFFRQPTVAGASKTRPDFRALVTNKPVVSALHGAVPGRFQKDICIGNQSNPCVPNNKNPRAFNGSSNGHVYEKLSSIESDV
    Show/Hide
Organism
Mus musculus, Mouse
Protein Classification
Ion channel
>
Ligand-gated ion channel
>
Ionotropic glutamate receptor
>
NMDA receptor
Function
Component of NMDA receptor complexes that function as heterotetrameric, ligand-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Channel activation requires binding of the neurotransmitter glutamate to the epsilon subunit, glycine binding to the zeta subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed:1377365, PubMed:26912815). Sensitivity to glutamate and channel kinetics depend on the subunit composition (PubMed:1377365). In concert with DAPK1 at extrasynaptic sites, acts as a central mediator for stroke damage. Its phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor channel activity inducing injurious Ca2+ influx through them, resulting in an irreversible neuronal death (PubMed:20141836). Contributes to neural pattern formation in the developing brain (PubMed:8789948). Plays a role in long-term depression (LTD) of hippocampus membrane currents and in synaptic plasticity (PubMed:8789948).
    Show/Hide
Uniprot ID
Primary ID:
Q01097

Secondarily ID:
Q9DCB2
    Show/Hide
Ensembl ID
ENSG00000273079
Subcellular Location
Cell membrane
Postsynaptic cell membrane
Late endosome
Lysosome
Cytoplasm
Cytoskeleton
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0389779
2-[4-[(4-fluorophenyl)methyl]-1-hydroxycyclohexyl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C22H23FN2O4
 1
1
IC50 = 0.631 nM
   TI
   LI
   LO
   TS
CP0475327
2-(4-benzyl-1-hydroxycyclohexyl)-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C22H24N2O4
 1
1
IC50 = 0.631 nM
   TI
   LI
   LO
   TS
CP0446865
5-[3-[[4-[(4-chlorophenyl)methyl]-1-hydroxycyclohexyl]methyl]-1,2-oxazol-5-yl]-1H-pyridin-2-one
   Show/Hide
C22H23ClN2O3
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0495646
2-[1-hydroxy-4-[(4-methoxyphenyl)methyl]cyclohexyl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C23H26N2O5
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0551719
2-[4-[3-fluoro-4-(trifluoromethyl)phenyl]piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H16F4N4O4
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0563791
2-[4-(4-chloro-3-fluorophenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C19H16ClFN4O4
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0519976
CHEMBL4059534
   Show/Hide
C22H22F2N2O4
 1
1
IC50 = 1.995 nM
   TI
   LI
   LO
   TS
CP0479209
2-[(2R)-4-(4-chloro-3-fluorophenyl)-2-methylpiperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H18ClFN4O4
 1
1
IC50 = 1.995 nM
   TI
   LI
   LO
   TS
CP0008021
2-[4-(4-Fluoro-benzyl)-piperidin-1-yl]-2-oxo-N-(2-oxo-2,3-dihydro-benzooxazol-6-yl)-acetamide
   Show/Hide
C21H20FN3O4
 1
1
IC50 = 3.162 nM
   TI
   LI
   LO
   TS
CP0389781
2-[4-[(4-chlorophenyl)methyl]-1-hydroxycyclohexyl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C22H23ClN2O4
 1
1
IC50 = 3.162 nM
   TI
   LI
   LO
   TS
CP0430565
2-[1-hydroxy-4-[[4-(trifluoromethoxy)phenyl]methyl]cyclohexyl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C23H23F3N2O5
 1
1
IC50 = 3.162 nM
   TI
   LI
   LO
   TS
CP0552131
2-[(3R)-4-(4-chloro-3-fluorophenyl)-3-methylpiperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H18ClFN4O4
 1
1
IC50 = 3.162 nM
   TI
   LI
   LO
   TS
CP0430564
4-[(4-chlorophenyl)methyl]-1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]cyclohexan-1-ol
   Show/Hide
C20H22ClN3O2
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0519975
2-[1-hydroxy-4-[[4-(trifluoromethyl)phenyl]methyl]cyclohexyl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C23H23F3N2O4
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0426314
2-[(2R)-4-(4-chlorophenyl)-2-methylpiperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H19ClN4O4
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0455889
2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)-2-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]acetamide
   Show/Hide
C20H17F3N4O4
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0476172
2-[(2R)-4-(3,4-difluorophenyl)-2-methylpiperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H18F2N4O4
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0479203
2-[(3R)-4-(4-chlorophenyl)-3-methylpiperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H19ClN4O4
 1
1
IC50 = 6.31 nM
   TI
   LI
   LO
   TS
CP0476275
2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C19H17ClN4O4
 1
1
IC50 = 7.943 nM
   TI
   LI
   LO
   TS
CP0475325
CHEMBL4103672
   Show/Hide
C24H28N2O3
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0552792
5-[3-[(4-benzyl-1-hydroxycyclohexyl)methyl]-1,2-oxazol-5-yl]-1H-pyridin-2-one
   Show/Hide
C22H24N2O3
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0476276
2-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C19H16F2N4O4
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0476277
2-[4-(3-chloro-4-fluorophenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C19H16ClFN4O4
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0551720
2-[(3R)-4-(3,4-difluorophenyl)-3-methylpiperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H18F2N4O4
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0555272
5-[3-[4-[(4-chlorophenyl)methyl]piperidine-1-carbonyl]-1,2-oxazol-5-yl]-1H-pyridin-2-one
   Show/Hide
C21H20ClN3O3
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0390446
4-[(4-fluorophenyl)methyl]-1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]cyclohexan-1-ol
   Show/Hide
C20H22FN3O2
 1
1
IC50 = 12.59 nM
   TI
   LI
   LO
   TS
CP0495652
1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]-4-[[4-(trifluoromethyl)phenyl]methyl]cyclohexan-1-ol
   Show/Hide
C21H22F3N3O2
 1
1
IC50 = 12.59 nM
   TI
   LI
   LO
   TS
CP0563482
1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]-4-[[4-(trifluoromethyl)phenyl]methyl]cyclohexan-1-ol
   Show/Hide
C21H22F3N3O2
 1
1
IC50 = 12.59 nM
   TI
   LI
   LO
   TS
CP0389780
2-(4-benzyl-1-hydroxycyclohexyl)-N-(2-oxo-1,3-dihydroindol-5-yl)acetamide
   Show/Hide
C23H26N2O3
 1
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
CP0410603
6-[3-[(4-benzyl-1-hydroxycyclohexyl)methyl]-1,2-oxazol-5-yl]-3H-1,3-benzoxazol-2-one
   Show/Hide
C24H24N2O4
 1
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
CP0415337
2-(4-benzyl-1-hydroxycyclohexyl)-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C22H24N2O4
 1
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
CP0529614
2-[4-[(4-fluorophenyl)methyl]-1-hydroxycyclohexyl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C22H23FN2O4
 1
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
CP0558614
4-benzyl-1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]cyclohexan-1-ol
   Show/Hide
C20H23N3O2
 1
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
CP0426313
2-[4-(3-fluoro-4-methoxyphenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H19FN4O5
 1
1
IC50 = 15.85 nM
   TI
   LI
   LO
   TS
CP0389783
4-[(4-methoxyphenyl)methyl]-1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]cyclohexan-1-ol
   Show/Hide
C21H25N3O3
 1
1
IC50 = 25.12 nM
   TI
   LI
   LO
   TS
CP0410604
1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]-4-[[4-(trifluoromethoxy)phenyl]methyl]cyclohexan-1-ol
   Show/Hide
C21H22F3N3O3
 1
1
IC50 = 25.12 nM
   TI
   LI
   LO
   TS
CP0475324
2-(4-benzyl-1-hydroxycyclohexyl)-N-(1H-indazol-5-yl)acetamide
   Show/Hide
C22H25N3O2
 1
1
IC50 = 39.81 nM
   TI
   LI
   LO
   TS
CP0475326
6-[3-[[4-[(4-chlorophenyl)methyl]-1-hydroxycyclohexyl]methyl]-1,2-oxazol-5-yl]-3H-1,3-benzoxazol-2-one
   Show/Hide
C24H23ClN2O4
 1
1
IC50 = 39.81 nM
   TI
   LI
   LO
   TS
CP0519977
4-[(3,4-difluorophenyl)methyl]-1-[[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methyl]cyclohexan-1-ol
   Show/Hide
C20H21F2N3O2
 1
1
IC50 = 39.81 nM
   TI
   LI
   LO
   TS
CP0455887
5-[3-[4-[(4-fluorophenyl)methyl]piperidine-1-carbonyl]-1,2-oxazol-5-yl]-1H-pyridin-2-one
   Show/Hide
C21H20FN3O3
 1
1
IC50 = 39.81 nM
   TI
   LI
   LO
   TS
CP0563481
[4-[(4-chlorophenyl)methyl]piperidin-1-yl]-[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methanone
   Show/Hide
C19H19ClN4O2
 1
1
IC50 = 39.81 nM
   TI
   LI
   LO
   TS
CP0561676
(4-benzylpiperidin-1-yl)-[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methanone
   Show/Hide
C19H20N4O2
 1
1
IC50 = 50.12 nM
   TI
   LI
   LO
   TS
CP0529615
5-[3-[[4-[(4-chlorophenyl)methyl]-1-hydroxycyclohexyl]methyl]-1,2-oxazol-5-yl]-1H-pyridin-2-one
   Show/Hide
C22H23ClN2O3
 1
1
IC50 = 63.1 nM
   TI
   LI
   LO
   TS
CP0455888
2-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H19ClN4O4
 1
1
IC50 = 63.1 nM
   TI
   LI
   LO
   TS
CP0479201
5-[3-(4-benzylpiperidine-1-carbonyl)-1,2-oxazol-5-yl]-1H-pyridin-2-one
   Show/Hide
C21H21N3O3
 1
1
IC50 = 63.1 nM
   TI
   LI
   LO
   TS
CP0571479
[4-[(4-fluorophenyl)methyl]piperidin-1-yl]-[5-(1H-pyrazol-4-yl)-1,2-oxazol-3-yl]methanone
   Show/Hide
C19H19FN4O2
 1
1
IC50 = 63.1 nM
   TI
   LI
   LO
   TS
CP0455890
2-[4-(3,5-difluorophenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C19H16F2N4O4
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0476278
2-[(3S)-4-(4-chlorophenyl)-3-methylpiperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H19ClN4O4
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0394220
2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C19H17FN4O4
 1
1
IC50 = 125.89 nM
   TI
   LI
   LO
   TS
CP0564140
5-[3-[[4-[(4-chlorophenyl)methyl]-1-hydroxycyclohexyl]methyl]-1,2,4-oxadiazol-5-yl]-1H-pyridin-2-one
   Show/Hide
C21H22ClN3O3
 1
1
IC50 = 158.49 nM
   TI
   LI
   LO
   TS
CP0559056
CHEMBL4085797
   Show/Hide
C20H22ClN3O2
 1
1
IC50 = 199.53 nM
   TI
   LI
   LO
   TS
CP0563483
2-[4-(4-methoxyphenyl)piperazin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide
   Show/Hide
C20H20N4O5
 1
1
IC50 = 199.53 nM
   TI
   LI
   LO
   TS
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT02751 Glutamate receptor ionotropic, NMDA 2B Homo sapiens, Human